27794081|t|Reduced Chest and Abdominal Wall Mobility and Their Relationship to Lung Function, Respiratory Muscle Strength, and Exercise Tolerance in Subjects With COPD
27794081|a|Advanced air-flow limitation in patients with COPD leads to a reduction in vital capacity, respiratory muscle strength, and exercise capacity. However, its impact on chest and abdominal wall mobility is unknown. This study aimed to ascertain the prevalence of patients with COPD with reduced chest and abdominal wall mobility and to investigate the effect of reduced chest and abdominal wall mobility on pulmonary function, respiratory muscle strength, and exercise capacity. In 51 elderly male subjects with COPD, chest and abdominal wall mobility, FVC, FEV1, FEV1/FVC, maximal inspiratory pressure (PImax), maximal expiratory pressure (PEmax), and the 6-min walk distance (6MWD) were assessed. Chest and abdominal wall mobility were measured using the breathing movement scale (0-8) at the 3 regions (upper chest, lower chest, and abdomen). Reduced mobility was defined as a value lower than the lower limit of the normal scale. The unpaired t test, Mann-Whitney test, and multiple regression analysis were performed. The percentages of subjects with reduced mobility were 78% for the upper chest, 76% for the lower chest, and 53% for the abdomen. The subjects with reduced mobility had significantly low FVC, FEV1, and 6MWD in each region and significantly low FEV1/FVC, PImax, and PEmax in the abdominal region compared with those with nonreduced mobility. FVC and 6MWD were independently associated with the scale values in each region and with the abdominal scale value, respectively. The majority of subjects with COPD had reduced chest and abdominal wall mobility, which was independently associated with FVC. Even though abdominal wall mobility was relatively preserved compared with chest wall mobility, it was also independently associated with 6MWD.
27794081	0	13	Reduced Chest	T033	C0577943
27794081	18	32	Abdominal Wall	T023	C0836916
27794081	33	41	Mobility	T080	C0449580
27794081	52	64	Relationship	T080	C0439849
27794081	68	81	Lung Function	T039	C0035245
27794081	83	94	Respiratory	T169	C0521346
27794081	95	110	Muscle Strength	T042	C0517349
27794081	116	134	Exercise Tolerance	T201	C0162521
27794081	138	146	Subjects	T096	C0681850
27794081	152	156	COPD	T047	C0024117
27794081	166	174	air-flow	T039	C0231999
27794081	175	185	limitation	T169	C0449295
27794081	189	197	patients	T101	C0030705
27794081	203	207	COPD	T047	C0024117
27794081	219	228	reduction	T080	C0392756
27794081	232	246	vital capacity	T201	C0042834
27794081	248	259	respiratory	T169	C0521346
27794081	260	275	muscle strength	T042	C0517349
27794081	281	298	exercise capacity	T201	C0162521
27794081	323	328	chest	T029	C0817096
27794081	333	347	abdominal wall	T023	C0836916
27794081	348	356	mobility	T080	C0449580
27794081	360	367	unknown	T080	C0439673
27794081	403	413	prevalence	T081	C0033106
27794081	417	425	patients	T101	C0030705
27794081	431	435	COPD	T047	C0024117
27794081	441	454	reduced chest	T033	C0577943
27794081	459	473	abdominal wall	T023	C0836916
27794081	474	482	mobility	T080	C0449580
27794081	490	501	investigate	T169	C1292732
27794081	506	512	effect	T080	C1280500
27794081	516	529	reduced chest	T033	C0577943
27794081	534	548	abdominal wall	T023	C0836916
27794081	549	557	mobility	T080	C0449580
27794081	561	579	pulmonary function	T039	C0035245
27794081	581	592	respiratory	T169	C0521346
27794081	593	608	muscle strength	T042	C0517349
27794081	614	631	exercise capacity	T201	C0162521
27794081	639	646	elderly	T098	C0001792
27794081	647	651	male	T032	C0086582
27794081	652	660	subjects	T096	C0681850
27794081	666	670	COPD	T047	C0024117
27794081	672	677	chest	T029	C0817096
27794081	682	696	abdominal wall	T023	C0836916
27794081	697	705	mobility	T080	C0449580
27794081	707	710	FVC	T034	C3714541
27794081	712	716	FEV1	T060	C0849974
27794081	718	726	FEV1/FVC	T059	C3815113
27794081	728	756	maximal inspiratory pressure	T060	C4083126
27794081	758	763	PImax	T060	C4083126
27794081	766	793	maximal expiratory pressure	T060	C4082175
27794081	795	800	PEmax	T060	C4082175
27794081	811	830	6-min walk distance	T060	C0430515
27794081	832	836	6MWD	T060	C0430515
27794081	843	851	assessed	T052	C1516048
27794081	853	858	Chest	T023	C0205076
27794081	863	877	abdominal wall	T023	C0836916
27794081	878	886	mobility	T080	C0449580
27794081	892	900	measured	T080	C0444706
27794081	911	920	breathing	T040	C0004048
27794081	921	935	movement scale	T059	C0022885
27794081	951	958	regions	T029	C0005898
27794081	960	971	upper chest	T029	C0446469
27794081	973	984	lower chest	T029	C0446470
27794081	990	997	abdomen	T029	C0000726
27794081	1000	1016	Reduced mobility	T033	C0700572
27794081	1034	1039	value	T081	C1522609
27794081	1040	1045	lower	T052	C2003888
27794081	1055	1086	lower limit of the normal scale	T081	C1518030
27794081	1092	1107	unpaired t test	T170	C1710574
27794081	1109	1126	Mann-Whitney test	T170	C1708930
27794081	1132	1160	multiple regression analysis	T080	C0681923
27794081	1166	1175	performed	T169	C0884358
27794081	1181	1192	percentages	T081	C0439165
27794081	1196	1204	subjects	T096	C0681850
27794081	1210	1226	reduced mobility	T033	C0700572
27794081	1244	1255	upper chest	T029	C0446469
27794081	1269	1280	lower chest	T029	C0446470
27794081	1298	1305	abdomen	T029	C0000726
27794081	1311	1319	subjects	T096	C0681850
27794081	1325	1341	reduced mobility	T033	C0700572
27794081	1346	1363	significantly low	T081	C4055638
27794081	1364	1367	FVC	T034	C3714541
27794081	1369	1373	FEV1	T060	C0849974
27794081	1379	1383	6MWD	T060	C0430515
27794081	1392	1398	region	T029	C0005898
27794081	1403	1420	significantly low	T081	C4055638
27794081	1421	1429	FEV1/FVC	T059	C3815113
27794081	1431	1436	PImax	T060	C4083126
27794081	1442	1447	PEmax	T060	C4082175
27794081	1455	1471	abdominal region	T029	C1720043
27794081	1472	1480	compared	T052	C1707455
27794081	1508	1516	mobility	T080	C0449580
27794081	1518	1521	FVC	T034	C3714541
27794081	1526	1530	6MWD	T060	C0430515
27794081	1550	1565	associated with	T080	C0332281
27794081	1570	1582	scale values	T080	C0042295
27794081	1591	1597	region	T029	C0005898
27794081	1611	1620	abdominal	T029	C0000726
27794081	1621	1632	scale value	T080	C0042295
27794081	1664	1672	subjects	T096	C0681850
27794081	1678	1682	COPD	T047	C0024117
27794081	1687	1700	reduced chest	T033	C0577943
27794081	1705	1719	abdominal wall	T023	C0836916
27794081	1720	1728	mobility	T080	C0449580
27794081	1754	1769	associated with	T080	C0332281
27794081	1770	1773	FVC	T034	C3714541
27794081	1787	1801	abdominal wall	T023	C0836916
27794081	1802	1810	mobility	T080	C0449580
27794081	1836	1844	compared	T052	C1707455
27794081	1850	1860	chest wall	T023	C0205076
27794081	1861	1869	mobility	T080	C0449580
27794081	1897	1912	associated with	T080	C0332281
27794081	1913	1917	6MWD	T060	C0430515